Active substances
Cx 045346 + Mrna1273 167 lnp b
- SFDA 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Spikevax LP.8.1 dispersion for injection in pre filled syringe | 2,0.1 mg/ml,mg/ml | Concentrate for dispersion for injection · Intramuscular use | 1 Pre-filled syringe | SAR 383.80 | Biological · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.